Benchstrength

Megan Maloney, the founder and General Partner, leads all investment decisions. She is joined by Partner Seyonne Kang. The firm operates with a deliberately flat structure — investment committee decisions move through Maloney and Kang with no external approval layer. This is a structural choice designed to allow term sheets to go out within days of a partner meeting.

Benchstrength writes initial checks of $500K to $2M and targets meaningful ownership in pre-seed and seed rounds. The firm prefers to lead or co-lead and reserves follow-on capital to maintain pro-rata through Series A — a posture that requires the fund to concentrate capital rather than spray across dozens of names per vintage.

Megan Maloney spent five years at Bain Capital Ventures before founding Benchstrength in 2023. At BCV she backed Hightouch, Pocus, and Mux — all technical-founder-led enterprise companies that raised priced seed rounds. That pattern of backing builders over career founders is the through-line in Benchstrength's stated strategy.

Yes. Benchstrength held a first close on its debut fund in April 2024 and is actively deploying. The fund targets $25M to $30M in total commitments — a size that allows the team to write concentrated seed checks without raising a vehicle too large for the ownership targets the firm has described.

The firm has not published a formal exclusion list, but its public investment record and stated focus point clearly toward enterprise software, AI/ML infrastructure, fintech, and developer tools. Hardware, consumer social, and capital-intensive industrial technology fall outside the pattern of technical-founder software businesses Maloney has backed across her career.

Benchstrength will co-lead and lead rounds but has publicly welcomed syndicate partners as a structural norm — the small fund size means it often builds rounds alongside other seed-stage firms rather than competing for whole deals. The firm's Bain Capital Ventures network and Maloney's established LP relationships provide a syndication advantage that solo GPs without an institutional background typically lack.

The firm reserves significant follow-on capital to maintain pro-rata through Series A. This is a core underwriting commitment — Maloney has described seed investing as a rights accumulation exercise, not just an initial check. The fund's compact target size relative to its ownership goals leaves explicit room for follow-on allocations.